Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study

Péchevis, M., Clarke, C. E., Vieregge, P., Khoshnood, B., Deschaseaux‐Voinet, C., Berdeaux, G., Ziegler, M., on behalf of the Trial Study Group·2005·European Journal of Neurology

Abstract

The treatment of Parkinson's disease (PD) with l‐DOPA leads to involuntary movements (dyskinesias). This 6‐month observational study in three European countries in PD patients with various degrees of motor complications examined the effects of dyskinesias on the quality of life (QoL) of patients and health care costs. Retrospective and prospective health economic data were collected, and QoL of patients was measured using the Short Form‐36 (SF‐36) and the PD Quality of Life (PDQL) Scale. Regression analysis was used to estimate the adjusted effects of dyskinesias on QoL and costs, whilst accounting for the potentially confounding effects of disease progression, motor fluctuations and country. Increasing dyskinesia scores on either the Unified PD Rating Scale or the Goetz Dyskinesia Rating Scale were associated with significant reductions in QoL scores on the SF‐36 and PDQL Scale. Increasing dyskinesia severity was also associated with increased depression scores on the Montgomery–Asberg Depression Rating Scale along with significant increases in health care costs. The effects of dyskinesia on QoL, depression and costs decreased but remained significant after adjustment for the confounding effects of disease progression and motor fluctuations. In conclusion, dyskinesias may adversely affect QoL and increase health care costs in patients with PD. Future studies should evaluate the potentially beneficial effects in terms of QoL and health care costs of strategies to delay the onset of, or the treatment of, dyskinesias.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2005.01096.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 196

Metadata

Authors
Péchevis, M., Clarke, C. E., Vieregge, P., Khoshnood, B., Deschaseaux‐Voinet, C., Berdeaux, G., Ziegler, M., & on behalf of the Trial Study Group
Venue
European Journal of Neurology
Publisher
Wiley
Published
2005-11-30
Volume
12
Issue
12
Pages
956-963
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2108369591
Cited by
196
References
4
FWCI
5.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study. https://app.cochat.ai/papers/10.1111/j.1468-1331.2005.01096.x
The paper
Péchevis, M., Clarke, C. E., Vieregge, P., Khoshnood, B., Deschaseaux‐Voinet, C., Berdeaux, G., Ziegler, M., & on behalf of the Trial Study Group. (2005). Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2005.01096.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.